Ensol Biosciences Inc.

Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.

140610 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 대전광역시 유성구 테크노10로 51(탑립동), 대전광역시
Website:: https://www.ensolbio.co.kr/eng/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Ensol Biosciences Inc. is a clinical-stage biopharmaceutical company developing innovative drugs for diseases with high unmet medical needs. The company specializes in creating PPI (Protein-Protein Interaction)-regulating short peptide drugs, utilizing a proprietary bio big data and AI platform for discovery and development. Its therapeutic approach focuses on local, non-blood injections to maximize efficacy, ensure high target specificity, and minimize systemic side effects due to a short half-life in the bloodstream. Ensol's clinical pipeline targets conditions such as osteoarthritis, degenerative disc disease, cancer, and Alzheimer's disease. Key candidates include E1K for osteoarthritis (preparing for Phase 3) and C1K, a combination cancer therapy (Phase 1).

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Ensol Biosciences Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Ensol Biosciences Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Ensol Biosciences Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Hyundai ADM Bio lnc. Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.	South Korea	187660
HYUNDAI BIOSCIENCE CO., LTD. Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.	South Korea	048410
IMGT Corporation Limited Develops a drug delivery platform using ultrasound and nanotech for oncology.	South Korea	456570
Immunic AG Developing oral therapies for autoimmune diseases like multiple sclerosis and celiac disease.	United States of America	IMUX
i-mobile Co.,Ltd. Operates one of Japan's largest ad networks and a 'Furusato Nozei' tax donation website.	Japan	6535
INBIOGEN CO.,Ltd Data mining, bioinformatics, and virtual assistance for the life sciences industry.	South Korea	101140
Incross Co.,Ltd. A digital marketing firm offering data-driven ad solutions via proprietary AI and video platforms.	South Korea	216050
INEST,Inc. Offers ASP solutions and HR support to businesses and sells mobile devices to consumers.	Japan	7111
Innate Pharma Clinical-stage biotech developing NK cell-engaging antibodies for cancer immunotherapy.	France	IPH
Innovation Inc. Drives B2B growth via digital media, IT solutions, M&A advisory, and venture capital.	Japan	3970